References
- Faulkenberry, G. D. and J. C. Daly. 1970. Sample size for tolerance limits on a normal distribution. Technometrics 12:813–21.
- Faulkenberry, G. D. and D. L. Weeks. 1968. Sample size determination for tolerance limits. Technometrics 10:343–48. doi:10.1080/00401706.1968.10490566.
- Fleiss, J. L. 1971. On the distribution of a linear combination of independent chi squares. Journal of the American Statistical Association 66:142–44.
- Hoffman, D. and R. Kringle. 2005. Two-sided tolerance intervals for balanced and unbalanced random effects models. Journal of Biopharmaceutical Statistics 152:283–93.
- Hung, H. M. J., S. J. Wang, and R. T. ONeill. 2010. Consideration of regional difference in design and analysis of multi-regional trials. Pharmaceutical Statistics 92:173–78.
- ICH, International Conference on Harmonisation. 1998. Tripartite guidance E5 ethnic factors in the acceptability of foreign data. The U.S. Federal Register 83:31790–96.
- ICH, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2006. Q&A for the ICH E5 Guldeline on Ethnic Factors in the Acceptability of Foreign Data. Available at: http://www.ich.org/LOB/media/MEDIA 1194.pdf.
- Kawai, N., C. Stein, O. Komiyama, and Y. Li. 2008. An approach to rationalize partitioning sample size into individual regions in a multiregional trial. Drug Information Journal 42 (2):139–47.
- Ko, F. S. 2016a. Sample size determination for quality control process using a multiple components tolerance interval. Communications in Statistics-Theory and Methods 45 (12):3668–74.
- Ko, F. S. 2016b. Comparisons of allocating sample size rationally into individual regions under heterogeneous effect size in a multiregional trial by a fixed effect model and a random effect model. Communications in Statistics-Theory and Methods 45 (23):7060–74.
- Ko, F. S., H. H. Tsou, J. P. Liu, and C. F. Hsiao. 2010. An approach to rationalize partitioning sample size into individual regions in a multiregional trial. Journal of Biopharmaceutical Statistics 20 (4):870–85.
- Kong. A. 1992. A note on importance sampling using standardized weights. Technical Report 348. Department of Statistics, University of Chicago.
- Martino, L., V. Elvira, and F. Louzada. 2017. Effective sample size for importance sampling based on discrepancy measures. Signal Processing 131:386–401.
- Ministry of Health, Labour and Welfare of Japan. 2007. Basic principles on global clinical trials. Tokyo: MHLW.
- Quan, H., M. Li, J. Chen, P. Gallo, B. Binkowitz, E. Ibia, Y. Tanaka, S. P. Ouyang, X. Luo, G. Li, et al. 2010. Assessment of consistency of treatment effects in multiregional clinical trials. Drug information Journal 44:617–32.
- Satterthwaite, F. E. 1946. An approximate distribution of estimates of variance components. Biometrics 2:110–14.